Nova Patents
IL230665B

17-hydroxyprogesterone ester-containing oral compositions and related methods

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

45 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
201113193571United States of AmericaA
201113193571United States of AmericaA
2012048708United States of AmericaW
2012048708United States of AmericaW
13193571–––
PCTUS2012048708–––
US201113193571–––
WO2012US48708–––

Members45

Family members, oldest first
DocumentOfficeKind
CA2879401A1CanadaA1
US2013029957A1United States of AmericaA1
WO2013016697A2World Intellectual Property Organization (WIPO)A2
WO2013016697A3World Intellectual Property Organization (WIPO)A3
AU2012286620A1AustraliaA1
IL230665D0IsraelD0
CN103826640AChinaA
KR20140064819ARepublic of KoreaA
EP2736515A2European Patent Office (EPO)A2
JP2014521660AJapanA
US2014271882A1United States of AmericaA1
ZA201401464BSouth AfricaB
EP2736515A4European Patent Office (EPO)A4
US2014377317A1United States of AmericaA1
US8951996B2United States of AmericaB2
US2015165049A1United States of AmericaA1
RU2014102285ARussian FederationA
US2015320768A1United States of AmericaA1
US9358298B2United States of AmericaB2
US9358299B2United States of AmericaB2
US9364547B2United States of AmericaB2
US9399069B2United States of AmericaB2
US2016213686A1United States of AmericaA1
NZ620698ANew ZealandA
US2017007623A1United States of AmericaA1
BR112014001942A2BrazilA2
AU2012286620B2AustraliaB2
CA2879401CCanadaC
JP2017193554AJapanA
RU2640912C2Russian FederationC2
IL230665AIsraelA
IL230665BThis recordIsraelB
US10022384B2United States of AmericaB2
CN108514545AChinaA
US2018289724A1United States of AmericaA1
JP6479470B2JapanB2
KR101957264B1Republic of KoreaB1
MX2014001101AMexicoA
US2019307775A1United States of AmericaA1
BR112014001942B1BrazilB1
EP2736515B1European Patent Office (EPO)B1
US10709716B2United States of AmericaB2
EP3763360A1European Patent Office (EPO)A1
US2021106596A1United States of AmericaA1
US11471470B2United States of AmericaB2